Research Article
Analysis of Cause-Specific Mortality in Patients with Retinoblastoma
Table 1
Characteristics of 12 RB cause-specific mortality patients.
| | Characteristics | Cause-specific mortality (N = 12) |
| | Diagnosis date | 2007–2019 | | Sex | | | Male | 6 (50.0%) | | Female | 6 (50.0%) | | Laterality | | | Unilateral | 6 (50.0%) | | Bilateral | 6 (50.0%) | | Initial symptom | | | Leukocoria | 10 (83.3%) | | Vision loss | 1 (8.3%) | | Hypopyon | 1 (8.3%) | | Patients source | | | Primary hospital | 9 (75.0%) | | Referral | 2 (16.7%) | | Consultant | 1 (8.3%) | | Family history | | | No | 11 (91.7%) | | Yes | 1 (8.3%) | | Initial treatment | | | IVC | 9 (75.0%) | | IAC | 1 (8.3%) | | Enucleation | 2 (16.7%) | | Last therapy | | | Chemotherapy | 10 (83.3%) | | Surgery | 1 (8.3%) | | Radiotherapy | 1 (8.3%) | | Direct death reason | | | Intracranial infection | 5 (41.7%) | | Cerebral hemorrhage | 3 (25.0%) | | Respiratory failure | 2 (16.7%) | | Paraplegia | 2 (16.7%) |
|
|